Hexo Corp (NASDAQ: HEXO) has announced the resignation of Sebastien St-Louis from the Board of Directors. Also, the company has appointed Scott Cooper as the CEO and President and will replace Sebastien St-Louis as Board Director.
Chairperson of the Hexo Board, Michael Munzar, said, “I would like to take this opportunity to thank Sebastien for over eight years of service on HEXO’s Board of Directors. Through his years of dedication, he has helped build HEXO into a market leader in Canada.”
Tauriga appoint Matthew Shaw to the advisory board
Tauriga Sciences Inc. (OTCMKTS: TAUG) has announced the appointment of Matthew A. Shaw to the Corporate Advisory Board. Matthew currently serves as Mergers & Acquisitions/Tax Head for US operations of Nestle.
In the Corporate Advisory Board role, Matthew will focus on helping Tauriga in general strategic advisory in the evaluation of market expansion opportunities and revenue growth avenues. Matthew is the brother of Tauriga’s CEO, and his business acumen will serve the company well in the advisory role.
Canopy makes executive changes
Canopy Growth Corporation (NASDAQ: CGC) has also made strategic changes to the Executive Management Committee. As a result, Mike Lee EVP, CFO, and Rade Kovacevic, President and Chief Product Officer, will resign from their roles immediately and depart the company on December 31, 2021.
CEO David Klein commented, “These decisions reflect Management and the Board’s vision for building a best-in-class organization that is well-positioned to deliver long-term growth and shareholder value. We appreciate Mike and Rade’s contributions to advancing Canopy Growth to our position as a cannabis industry leader.”
CV Sciences appoint a new accounting firm
CV Sciences Inc. (OTCMKTS: CVSI) has announced the appointment of Haskell & White LLP as its New independent accounting company.
CEO of CV Sciences Jospeh Dowling said, “Following a thorough selection process, the Company’s Audit Committee has concluded that H&W is best positioned to meet the evolving needs of CV Sciences. This is the result of our ongoing efforts to implement cost efficiencies to fully leverage our business model.”